The 6th UK Patient Reported Outcome Measures (PROMs) Research Conference was held on the 14th and 15th of June 2022. Hosted online, it attracted an international audience from locations including Europe, the USA, Australia, New Zealand, and the Caribbean, and was attended by 381 people with representatives from academia, healthcare, patients, and industry. Previously hosted by the Universities of Sheffield, Oxford, Birmingham and Leeds Beckett, for the first time it was hosted by a non-academic organisation, making its inaugural visit to Wales, and was hosted by The Welsh Value in Health Centre. Welcoming abstracts on any topics, focused themes included: Methods; Implementation; Palliative Care; COVID-19; Patient and Public Involvement; Men...
Introduction More people are living with and beyond a cancer diagnosis. There is limited understand...
In 2002, the NIH launched the ‘Roadmap for Medical Research’. The Patient-Reported Outcomes Measurem...
The 5th EORTC Quality of Life in Cancer Clinical Trials Conference presented the current state of qu...
The 6th UK Patient Reported Outcome Measures (PROMs) Research Conference was held on the 14th and 15...
Table of contents S1 Using computerized adaptive testing Tim Croudace S2 Well-being: what is it, how...
The proceedings contain 36 papers. The topics discussed include: using patient reported outcome meas...
The patient is the most reliable reporter of their symptoms, function and health-related quality of ...
Jonathan P Evans,1 Alexander Smith,2 Chris Gibbons,3 Jordi Alonso,4–6 Jose M Valderas1 1Health...
The use of Patient Reported Outcome Measures (PROMs) is increasingly important in clinical practice....
Aims: People living with treatable but not curable cancer often experience a range of symptoms rela...
Purpose: The added value of measuring patient-reported outcomes (PROs) for delivering patient-center...
Patient-reported outcome measurement (PROM) plays an increasing role in palliative and end-of-life (...
This is the final version. Available on open access from BMJ Publishing Group via the DOI in this re...
In recent years, there has been an increased focus on placing patients at the center of health care ...
PurposeThe added value of measuring patient-reported outcomes (PROs) for delivering patient-centered...
Introduction More people are living with and beyond a cancer diagnosis. There is limited understand...
In 2002, the NIH launched the ‘Roadmap for Medical Research’. The Patient-Reported Outcomes Measurem...
The 5th EORTC Quality of Life in Cancer Clinical Trials Conference presented the current state of qu...
The 6th UK Patient Reported Outcome Measures (PROMs) Research Conference was held on the 14th and 15...
Table of contents S1 Using computerized adaptive testing Tim Croudace S2 Well-being: what is it, how...
The proceedings contain 36 papers. The topics discussed include: using patient reported outcome meas...
The patient is the most reliable reporter of their symptoms, function and health-related quality of ...
Jonathan P Evans,1 Alexander Smith,2 Chris Gibbons,3 Jordi Alonso,4–6 Jose M Valderas1 1Health...
The use of Patient Reported Outcome Measures (PROMs) is increasingly important in clinical practice....
Aims: People living with treatable but not curable cancer often experience a range of symptoms rela...
Purpose: The added value of measuring patient-reported outcomes (PROs) for delivering patient-center...
Patient-reported outcome measurement (PROM) plays an increasing role in palliative and end-of-life (...
This is the final version. Available on open access from BMJ Publishing Group via the DOI in this re...
In recent years, there has been an increased focus on placing patients at the center of health care ...
PurposeThe added value of measuring patient-reported outcomes (PROs) for delivering patient-centered...
Introduction More people are living with and beyond a cancer diagnosis. There is limited understand...
In 2002, the NIH launched the ‘Roadmap for Medical Research’. The Patient-Reported Outcomes Measurem...
The 5th EORTC Quality of Life in Cancer Clinical Trials Conference presented the current state of qu...